Friday, August 11, 2023

Biocon may list biosimilars business by 2025 first half - CEO

Biocon may list biosimilars business by 2025 first half - CEO Biocon Biologics, a fully integrated subsidiary of Biocon Ltd, focuses on making biosimilars, with key revenue-generating markets being the United States and Europe.

from Moneycontrol Business News https://ift.tt/Z3v0XIh

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...